Gregory Schwartz, PhD, an RPB Career Development Award recipient, and his research collaborators at Northwestern University School of Medicine, recently published important discoveries related to blood vessel regulation in the journal Neuron. They identified nitric oxide-releasing amacrine cells as critical to blood vessel regulation in the retina and beyond.
The findings could impact diseases involving blood flow, such as diabetic retinopathy (DR). By detecting damage to nitric oxide-releasing amacrine cells, DR could potentially be diagnosed years earlier than is currently possible—before damage occurs. The knowledge gained through this research could even lead to new options for stroke treatment.
November 27, 2018
The new way to measure ocular aging opens treatment avenues for numerous eye diseases.
The American Academy of Ophthalmology (AAO) and Research to Prevent Blindness (RPB) today announced the 2023 recipients of the RPB/AAO Award for IRIS Registry Research.
RPB acknowledges the passing of a dedicated former Board member.
Patricia Ann D’Amore, PhD, MBA, is recognized for ground-breaking contributions to the field of vision research.
Dr. Akrit Sodhi at Johns Hopkins Medicine has published a new study showing promise for an experimental treatment to prevent or slow vision loss in people with diabetes.
RPB launches awards in data science and Diabetic Eye Disease.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |